Vimarsana
Biggest News Aggregation in the World

Key Markers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Key Markers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Key Markers Today - Breaking & Trending Today

Cardiol Therapeutics : MATERIAL CHANGE REPORT - Form 6-K -October 11, 2023 at 10:03 am EDT - Vimarsana News

Cardiol Therapeutics : MATERIAL CHANGE REPORT - Form 6-K -October 11, 2023 at 10:03 am EDT

MATERIAL CHANGE REPORT - Name and Address of Company Cardiol Therapeutics Inc. 2265 Upper Middle Road East, Suite 602 Oakville, Ontario,...

Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction - Vimarsana News

Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction

Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart...

Brain Aneurysm Foundation Announces 2023 Research Grants - Vimarsana News

Brain Aneurysm Foundation Announces 2023 Research Grants

/PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to transform the treatment of...

Akero Therapeutics' Phase 2b SYMMETRY Cohort D Study Met Safety & Tolerability Endpoints and Showed Adding EFX to GLP-1 Therapy Significantly Improved Non-Invasive Markers of NASH-Related Disease - Vimarsana News

Akero Therapeutics' Phase 2b SYMMETRY Cohort D Study Met Safety & Tolerability Endpoints and Showed Adding EFX to GLP-1 Therapy Significantly Improved Non-Invasive Markers of NASH-Related Disease

Patients treated with EFX for 12 weeks combined with GLP-1 achieved a 65% relative reduction in liver fat, compared to a 10% relative reduction for GLP-1 alone 88% of patients treated with EFX... | June 5, 2023

A Response To The New York Times' Ritualistic Denunciation Of Mao's Cultural Revolution... - Vimarsana News

A Response To The New York Times' Ritualistic Denunciation Of Mao's Cultural Revolution...

Or How Critical Thinking Is Deleted in “The Decade That Cannot Be Deleted”